Global Montelukast Sodium Preparations Market Growth 2026-2032

September 2026 | 112 pages | ID: G9751B84FAE1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Montelukast Sodium Preparations market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Montelukast Sodium Preparations players cover Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Montelukast Sodium Preparations Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Preparations sales in 2025, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Preparations sales for 2026 through 2032. With Montelukast Sodium Preparations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Preparations industry.

This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Preparations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Preparations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium Preparations market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Preparations and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Preparations.

This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Preparations market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Chewable Tablets
  • Regular Tablet
  • Particles
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Morepen Laboratories
  • Mylan
  • Teva Pharmaceuticals
  • Merck
  • Sandoz
  • Aurobindo Pharma
  • Otsuka Pharmaceutical
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Beijing Winsunny Pharmaceutical Co., Ltd.
  • Nanjing Hicin Pharmaceutical Co.,Ltd.
  • Zhejiang NuoDe Pharmaceutical Co.? Ltd.
  • Hefei Yingtai Pharmaceutical Co., Ltd.
  • Lunan Better Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical
  • CSPC Pharmaceutical Group Limited
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Montelukast Sodium Preparations market?
  • What factors are driving Montelukast Sodium Preparations market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Montelukast Sodium Preparations market opportunities vary by end market size?
  • How does Montelukast Sodium Preparations break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Montelukast Sodium Preparations Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Montelukast Sodium Preparations by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Montelukast Sodium Preparations by Country/Region, 2021, 2025 & 2032
  2.2 Montelukast Sodium Preparations Segment by Type
  2.2.1 Chewable Tablets
  2.2.2 Regular Tablet
  2.2.3 Particles
  2.2.4 Montelukast Sodium Preparations Sales by Type
  2.2.4.1 Global Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
  2.2.4.2 Global Montelukast Sodium Preparations Revenue and Market Share by Type (2021-2026)
  2.2.4.3 Global Montelukast Sodium Preparations Sale Price by Type (2021-2026)
  2.3 Montelukast Sodium Preparations Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Montelukast Sodium Preparations Sales by Application
  2.3.4.1 Global Montelukast Sodium Preparations Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Montelukast Sodium Preparations Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Montelukast Sodium Preparations Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Montelukast Sodium Preparations Breakdown Data by Company
  3.1.1 Global Montelukast Sodium Preparations Annual Sales by Company (2021-2026)
  3.1.2 Global Montelukast Sodium Preparations Sales Market Share by Company (2021-2026)
  3.2 Global Montelukast Sodium Preparations Annual Revenue by Company (2021-2026)
  3.2.1 Global Montelukast Sodium Preparations Revenue by Company (2021-2026)
  3.2.2 Global Montelukast Sodium Preparations Revenue Market Share by Company (2021-2026)
  3.3 Global Montelukast Sodium Preparations Sale Price by Company
  3.4 Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Montelukast Sodium Preparations Product Location Distribution
  3.4.2 Players Montelukast Sodium Preparations Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MONTELUKAST SODIUM PREPARATIONS BY GEOGRAPHIC REGION

  4.1 World Historic Montelukast Sodium Preparations Market Size by Geographic Region (2021-2026)
  4.1.1 Global Montelukast Sodium Preparations Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Montelukast Sodium Preparations Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Montelukast Sodium Preparations Market Size by Country/Region (2021-2026)
  4.2.1 Global Montelukast Sodium Preparations Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Montelukast Sodium Preparations Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Montelukast Sodium Preparations Sales Growth
  4.4 APAC Montelukast Sodium Preparations Sales Growth
  4.5 Europe Montelukast Sodium Preparations Sales Growth
  4.6 Middle East & Africa Montelukast Sodium Preparations Sales Growth

5 AMERICAS

  5.1 Americas Montelukast Sodium Preparations Sales by Country
  5.1.1 Americas Montelukast Sodium Preparations Sales by Country (2021-2026)
  5.1.2 Americas Montelukast Sodium Preparations Revenue by Country (2021-2026)
  5.2 Americas Montelukast Sodium Preparations Sales by Type (2021-2026)
  5.3 Americas Montelukast Sodium Preparations Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Montelukast Sodium Preparations Sales by Region
  6.1.1 APAC Montelukast Sodium Preparations Sales by Region (2021-2026)
  6.1.2 APAC Montelukast Sodium Preparations Revenue by Region (2021-2026)
  6.2 APAC Montelukast Sodium Preparations Sales by Type (2021-2026)
  6.3 APAC Montelukast Sodium Preparations Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Montelukast Sodium Preparations by Country
  7.1.1 Europe Montelukast Sodium Preparations Sales by Country (2021-2026)
  7.1.2 Europe Montelukast Sodium Preparations Revenue by Country (2021-2026)
  7.2 Europe Montelukast Sodium Preparations Sales by Type (2021-2026)
  7.3 Europe Montelukast Sodium Preparations Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Montelukast Sodium Preparations by Country
  8.1.1 Middle East & Africa Montelukast Sodium Preparations Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Montelukast Sodium Preparations Revenue by Country (2021-2026)
  8.2 Middle East & Africa Montelukast Sodium Preparations Sales by Type (2021-2026)
  8.3 Middle East & Africa Montelukast Sodium Preparations Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations
  10.3 Manufacturing Process Analysis of Montelukast Sodium Preparations
  10.4 Industry Chain Structure of Montelukast Sodium Preparations

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Montelukast Sodium Preparations Distributors
  11.3 Montelukast Sodium Preparations Customer

12 WORLD FORECAST REVIEW FOR MONTELUKAST SODIUM PREPARATIONS BY GEOGRAPHIC REGION

  12.1 Global Montelukast Sodium Preparations Market Size Forecast by Region
  12.1.1 Global Montelukast Sodium Preparations Forecast by Region (2027-2032)
  12.1.2 Global Montelukast Sodium Preparations Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Montelukast Sodium Preparations Forecast by Type (2027-2032)
  12.7 Global Montelukast Sodium Preparations Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Morepen Laboratories
  13.1.1 Morepen Laboratories Company Information
  13.1.2 Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
  13.1.3 Morepen Laboratories Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Morepen Laboratories Main Business Overview
  13.1.5 Morepen Laboratories Latest Developments
  13.2 Mylan
  13.2.1 Mylan Company Information
  13.2.2 Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
  13.2.3 Mylan Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Mylan Main Business Overview
  13.2.5 Mylan Latest Developments
  13.3 Teva Pharmaceuticals
  13.3.1 Teva Pharmaceuticals Company Information
  13.3.2 Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
  13.3.3 Teva Pharmaceuticals Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Teva Pharmaceuticals Main Business Overview
  13.3.5 Teva Pharmaceuticals Latest Developments
  13.4 Merck
  13.4.1 Merck Company Information
  13.4.2 Merck Montelukast Sodium Preparations Product Portfolios and Specifications
  13.4.3 Merck Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Merck Main Business Overview
  13.4.5 Merck Latest Developments
  13.5 Sandoz
  13.5.1 Sandoz Company Information
  13.5.2 Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
  13.5.3 Sandoz Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Sandoz Main Business Overview
  13.5.5 Sandoz Latest Developments
  13.6 Aurobindo Pharma
  13.6.1 Aurobindo Pharma Company Information
  13.6.2 Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
  13.6.3 Aurobindo Pharma Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Aurobindo Pharma Main Business Overview
  13.6.5 Aurobindo Pharma Latest Developments
  13.7 Otsuka Pharmaceutical
  13.7.1 Otsuka Pharmaceutical Company Information
  13.7.2 Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
  13.7.3 Otsuka Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Otsuka Pharmaceutical Main Business Overview
  13.7.5 Otsuka Pharmaceutical Latest Developments
  13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
  13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
  13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
  13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
  13.9 Beijing Winsunny Pharmaceutical Co., Ltd.
  13.9.1 Beijing Winsunny Pharmaceutical Co., Ltd. Company Information
  13.9.2 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.9.3 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Beijing Winsunny Pharmaceutical Co., Ltd. Main Business Overview
  13.9.5 Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
  13.10 Nanjing Hicin Pharmaceutical Co.,Ltd.
  13.10.1 Nanjing Hicin Pharmaceutical Co.,Ltd. Company Information
  13.10.2 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.10.3 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business Overview
  13.10.5 Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
  13.11 Zhejiang NuoDe Pharmaceutical Co.? Ltd.
  13.11.1 Zhejiang NuoDe Pharmaceutical Co.? Ltd. Company Information
  13.11.2 Zhejiang NuoDe Pharmaceutical Co.? Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.11.3 Zhejiang NuoDe Pharmaceutical Co.? Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Zhejiang NuoDe Pharmaceutical Co.? Ltd. Main Business Overview
  13.11.5 Zhejiang NuoDe Pharmaceutical Co.? Ltd. Latest Developments
  13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
  13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
  13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
  13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
  13.13 Lunan Better Pharmaceutical Co., Ltd.
  13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
  13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
  13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
  13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
  13.14 Qilu Pharmaceutical
  13.14.1 Qilu Pharmaceutical Company Information
  13.14.2 Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
  13.14.3 Qilu Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Qilu Pharmaceutical Main Business Overview
  13.14.5 Qilu Pharmaceutical Latest Developments
  13.15 CSPC Pharmaceutical Group Limited
  13.15.1 CSPC Pharmaceutical Group Limited Company Information
  13.15.2 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
  13.15.3 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 CSPC Pharmaceutical Group Limited Main Business Overview
  13.15.5 CSPC Pharmaceutical Group Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Montelukast Sodium Preparations Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Montelukast Sodium Preparations Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chewable Tablets
Table 4. Major Players of Regular Tablet
Table 5. Major Players of Particles
Table 6. Global Montelukast Sodium Preparations Sales by Type (2021-2026) & (K Units)
Table 7. Global Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
Table 8. Global Montelukast Sodium Preparations Revenue by Type (2021-2026) & ($ million)
Table 9. Global Montelukast Sodium Preparations Revenue Market Share by Type (2021-2026)
Table 10. Global Montelukast Sodium Preparations Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Montelukast Sodium Preparations Sale by Application (2021-2026) & (K Units)
Table 12. Global Montelukast Sodium Preparations Sale Market Share by Application (2021-2026)
Table 13. Global Montelukast Sodium Preparations Revenue by Application (2021-2026) & ($ million)
Table 14. Global Montelukast Sodium Preparations Revenue Market Share by Application (2021-2026)
Table 15. Global Montelukast Sodium Preparations Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Montelukast Sodium Preparations Sales by Company (2021-2026) & (K Units)
Table 17. Global Montelukast Sodium Preparations Sales Market Share by Company (2021-2026)
Table 18. Global Montelukast Sodium Preparations Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Montelukast Sodium Preparations Revenue Market Share by Company (2021-2026)
Table 20. Global Montelukast Sodium Preparations Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution and Sales Area
Table 22. Players Montelukast Sodium Preparations Products Offered
Table 23. Montelukast Sodium Preparations Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Montelukast Sodium Preparations Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Montelukast Sodium Preparations Sales Market Share Geographic Region (2021-2026)
Table 28. Global Montelukast Sodium Preparations Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Montelukast Sodium Preparations Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Montelukast Sodium Preparations Sales Market Share by Country/Region (2021-2026)
Table 32. Global Montelukast Sodium Preparations Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Montelukast Sodium Preparations Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Montelukast Sodium Preparations Sales by Country (2021-2026) & (K Units)
Table 35. Americas Montelukast Sodium Preparations Sales Market Share by Country (2021-2026)
Table 36. Americas Montelukast Sodium Preparations Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Montelukast Sodium Preparations Sales by Type (2021-2026) & (K Units)
Table 38. Americas Montelukast Sodium Preparations Sales by Application (2021-2026) & (K Units)
Table 39. APAC Montelukast Sodium Preparations Sales by Region (2021-2026) & (K Units)
Table 40. APAC Montelukast Sodium Preparations Sales Market Share by Region (2021-2026)
Table 41. APAC Montelukast Sodium Preparations Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Montelukast Sodium Preparations Sales by Type (2021-2026) & (K Units)
Table 43. APAC Montelukast Sodium Preparations Sales by Application (2021-2026) & (K Units)
Table 44. Europe Montelukast Sodium Preparations Sales by Country (2021-2026) & (K Units)
Table 45. Europe Montelukast Sodium Preparations Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Montelukast Sodium Preparations Sales by Type (2021-2026) & (K Units)
Table 47. Europe Montelukast Sodium Preparations Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Montelukast Sodium Preparations Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Montelukast Sodium Preparations Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Montelukast Sodium Preparations Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Montelukast Sodium Preparations Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Montelukast Sodium Preparations
Table 53. Key Market Challenges & Risks of Montelukast Sodium Preparations
Table 54. Key Industry Trends of Montelukast Sodium Preparations
Table 55. Montelukast Sodium Preparations Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Montelukast Sodium Preparations Distributors List
Table 58. Montelukast Sodium Preparations Customer List
Table 59. Global Montelukast Sodium Preparations Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Montelukast Sodium Preparations Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Montelukast Sodium Preparations Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Montelukast Sodium Preparations Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Montelukast Sodium Preparations Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Montelukast Sodium Preparations Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Montelukast Sodium Preparations Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Montelukast Sodium Preparations Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Montelukast Sodium Preparations Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Montelukast Sodium Preparations Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Montelukast Sodium Preparations Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Montelukast Sodium Preparations Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Montelukast Sodium Preparations Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Montelukast Sodium Preparations Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Morepen Laboratories Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 74. Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
Table 75. Morepen Laboratories Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Morepen Laboratories Main Business
Table 77. Morepen Laboratories Latest Developments
Table 78. Mylan Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
Table 80. Mylan Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Pharmaceuticals Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
Table 85. Teva Pharmaceuticals Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Teva Pharmaceuticals Main Business
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Merck Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Montelukast Sodium Preparations Product Portfolios and Specifications
Table 90. Merck Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Sandoz Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 94. Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
Table 95. Sandoz Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sandoz Main Business
Table 97. Sandoz Latest Developments
Table 98. Aurobindo Pharma Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 99. Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
Table 100. Aurobindo Pharma Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Aurobindo Pharma Main Business
Table 102. Aurobindo Pharma Latest Developments
Table 103. Otsuka Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 104. Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 105. Otsuka Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Otsuka Pharmaceutical Main Business
Table 107. Otsuka Pharmaceutical Latest Developments
Table 108. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 109. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 110. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 112. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 113. Beijing Winsunny Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 115. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beijing Winsunny Pharmaceutical Co., Ltd. Main Business
Table 117. Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
Table 118. Nanjing Hicin Pharmaceutical Co.,Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 119. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 120. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business
Table 122. Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
Table 123. Zhejiang NuoDe Pharmaceutical Co.? Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang NuoDe Pharmaceutical Co.? Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 125. Zhejiang NuoDe Pharmaceutical Co.? Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zhejiang NuoDe Pharmaceutical Co.? Ltd. Main Business
Table 127. Zhejiang NuoDe Pharmaceutical Co.? Ltd. Latest Developments
Table 128. Hefei Yingtai Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 129. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 130. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Hefei Yingtai Pharmaceutical Co., Ltd. Main Business
Table 132. Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
Table 133. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 134. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 135. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 137. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 138. Qilu Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 139. Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 140. Qilu Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Qilu Pharmaceutical Main Business
Table 142. Qilu Pharmaceutical Latest Developments
Table 143. CSPC Pharmaceutical Group Limited Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 144. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
Table 145. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. CSPC Pharmaceutical Group Limited Main Business
Table 147. CSPC Pharmaceutical Group Limited Latest Developments

LIST OF FIGURES

Figure 1. Picture of Montelukast Sodium Preparations
Figure 2. Montelukast Sodium Preparations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sodium Preparations Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Montelukast Sodium Preparations Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Montelukast Sodium Preparations Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Montelukast Sodium Preparations Sales Market Share by Country/Region (2025)
Figure 10. Montelukast Sodium Preparations Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Chewable Tablets
Figure 12. Product Picture of Regular Tablet
Figure 13. Product Picture of Particles
Figure 14. Global Montelukast Sodium Preparations Sales Market Share by Type in 2026
Figure 15. Global Montelukast Sodium Preparations Revenue Market Share by Type (2021-2026)
Figure 16. Montelukast Sodium Preparations Consumed in Hospital
Figure 17. Global Montelukast Sodium Preparations Market: Hospital (2021-2026) & (K Units)
Figure 18. Montelukast Sodium Preparations Consumed in Clinic
Figure 19. Global Montelukast Sodium Preparations Market: Clinic (2021-2026) & (K Units)
Figure 20. Montelukast Sodium Preparations Consumed in Other
Figure 21. Global Montelukast Sodium Preparations Market: Other (2021-2026) & (K Units)
Figure 22. Global Montelukast Sodium Preparations Sale Market Share by Application (2025)
Figure 23. Global Montelukast Sodium Preparations Revenue Market Share by Application in 2026
Figure 24. Montelukast Sodium Preparations Sales by Company in 2026 (K Units)
Figure 25. Global Montelukast Sodium Preparations Sales Market Share by Company in 2026
Figure 26. Montelukast Sodium Preparations Revenue by Company in 2026 ($ millions)
Figure 27. Global Montelukast Sodium Preparations Revenue Market Share by Company in 2026
Figure 28. Global Montelukast Sodium Preparations Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Montelukast Sodium Preparations Sales 2021-2026 (K Units)
Figure 31. Americas Montelukast Sodium Preparations Revenue 2021-2026 ($ millions)
Figure 32. APAC Montelukast Sodium Preparations Sales 2021-2026 (K Units)
Figure 33. APAC Montelukast Sodium Preparations Revenue 2021-2026 ($ millions)
Figure 34. Europe Montelukast Sodium Preparations Sales 2021-2026 (K Units)
Figure 35. Europe Montelukast Sodium Preparations Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Montelukast Sodium Preparations Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Montelukast Sodium Preparations Revenue 2021-2026 ($ millions)
Figure 38. Americas Montelukast Sodium Preparations Sales Market Share by Country in 2026
Figure 39. Americas Montelukast Sodium Preparations Revenue Market Share by Country (2021-2026)
Figure 40. Americas Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
Figure 41. Americas Montelukast Sodium Preparations Sales Market Share by Application (2021-2026)
Figure 42. United States Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Montelukast Sodium Preparations Sales Market Share by Region in 2026
Figure 47. APAC Montelukast Sodium Preparations Revenue Market Share by Region (2021-2026)
Figure 48. APAC Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
Figure 49. APAC Montelukast Sodium Preparations Sales Market Share by Application (2021-2026)
Figure 50. China Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 54. India Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Montelukast Sodium Preparations Sales Market Share by Country in 2026
Figure 58. Europe Montelukast Sodium Preparations Revenue Market Share by Country (2021-2026)
Figure 59. Europe Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
Figure 60. Europe Montelukast Sodium Preparations Sales Market Share by Application (2021-2026)
Figure 61. Germany Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 62. France Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Application (2021-2026)
Figure 69. Egypt Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Montelukast Sodium Preparations Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations in 2026
Figure 75. Manufacturing Process Analysis of Montelukast Sodium Preparations
Figure 76. Industry Chain Structure of Montelukast Sodium Preparations
Figure 77. Channels of Distribution
Figure 78. Global Montelukast Sodium Preparations Sales Market Forecast by Region (2027-2032)
Figure 79. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Montelukast Sodium Preparations Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Montelukast Sodium Preparations Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Application (2027-2032)


More Publications